Cytomegalovirus (CMV) is the leading cause of infectious birth defects and linked to many other morbidities such as with transplantation. For the first time after >50 years of pursuit, a vaccine is in reach jci.org/articles/vie...
We're pleased to share our first animation, that aims to grow potential participant awareness of PLATIPUS and how it works.
Special thanks to Stephanie Hebbard, Kelly Fredell, Tara Lofhelm, PLATIPUS Lived Experience Committee and others who helped create this.
www.platipustrial.org/participants...
So excited to share our commentary out now in LancetCAH and freely available via the link below!
The time is NOW for Adaptive Platform Trials to improve outcomes for preterm infants! @platipus.bsky.social
url.au.m.mimecastprotect.com/s/ukzLCmOxr6...
Have you read our article about adaptive platform trials for preterm birth yet? #neosky
We discuss the challenges facing perinatal clinical researchers and how traditional RCTs may no longer be fit for purpose in our field.
Are APTs the answer?
www.thelancet.com/journals/lan...
Well done Robyn and Della. It’s so important we maintain a skilled midwifery workforce to keep our patients safe and optimise outcomes.
Such a huge amount of work - the PLUSS trial published in JAMA by our own @drbretty.bsky.social
Exciting times ahead leading the PLATIPUS trial with @drbretty.bsky.social
Follow us or @platipus.bsky.social for updates on the PLATIPUS & its first 2 domains:
1. PROMOAT - best choice of ABx for PPROM
2. BabyCCINO - which caffeine citrate dose for very preterm infants
#NeoSky #NICUSky #ObGynSky
Great to see progress in stillbirth reduction - but so much still to be done
www.thelancet.com/journals/lan...
Video
url.au.m.mimecastprotect.com
In this Viewpoint, we discuss the challenges facing perinatal clinical researchers,
many of which are unique to this field, and how traditional two-arm randomised trials
using frequentist analysis mig...
Despite the gradual global decline in stillbirths between 1990 and 2021, the overall
number of stillbirths remains substantially high. Counting all stillbirths is paramount
to progress, as nearly a th...
If you haven’t caught up on the PLUSS trial results yet, published a few days ago in JAMA #neosky #nicusky
Link to paper: jamanetwork.com/journals/jam...
Link to editorial: jamanetwork.com/journals/jam...
Link to audio podcast: edhub.ama-assn.org/jn-learning/...
"I love my job. But it’s physically, mentally, & emotionally draining”: a cross-sectional survey exploring midwives’ intentions of leaving the profession
Robyn Matthews, Michelle Newton, Rebecca Hyde, Touran Shafiei, Fleur Llewelyn & Della Forster
bmchealthservres.biomedcentral.com/articles/10....
Introducing the PLATIPUS perinatal adaptive platform trial to #NeoSky #ObGynSky #NICUSky…
This randomized trial assesses the effect of intratracheal budesonide mixed with surfactant on survival free of bronchopulmonary dysplasia in extremely preterm infants.
Background Prior to the COVID-19 pandemic there were midwifery workforce deficits reported in Australia, but inadequate workforce data to identify retention and attrition in the profession. In the pos...
